Literature DB >> 23263456

[Lost in translation? On the effectiveness and efficacy of drotrecogin alfa (recombinant human activated protein C)].

H Gerlach1.   

Abstract

Entities:  

Year:  2013        PMID： 23263456     DOI： 10.1007/s00063-012-0206-y

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN： 2193-6218            Impact factor:   0.840


× No keyword cloud information.
  4 in total

1.  Effectiveness and safety of drotrecogin alfa (activated) for severe sepsis: a meta-analysis and metaregression.

Authors:  Andre C Kalil; Steven P LaRosa
Journal:  Lancet Infect Dis       Date:  2012-07-17       Impact factor: 25.071

2.  Evaluating the use of recombinant human activated protein C in adult severe sepsis: results of the Surviving Sepsis Campaign.

Authors:  Brian Casserly; Herwig Gerlach; Gary S Phillips; John C Marshall; Stanley Lemeshow; Mitchell M Levy
Journal:  Crit Care Med       Date:  2012-05       Impact factor: 7.598

3.  Activated protein C and septic shock: a propensity-matched cohort study*.

Authors:  Emily Rimmer; Anand Kumar; Steve Doucette; John Marshall; Sandra Dial; David Gurka; R Phillip Dellinger; Satendra Sharma; Charles Penner; Andreas Kramer; Kenneth Wood; John Ronald; Aseem Kumar; Alexis F Turgeon; Donald S Houston; Ryan Zarychanski
Journal:  Crit Care Med       Date:  2012-11       Impact factor: 7.598

Review 4.  An updated meta-analysis to understand the variable efficacy of drotrecogin alfa (activated) in severe sepsis and septic shock.

Authors:  P S Lai; A Matteau; A Iddriss; J C L Hawes; V Ranieri; B T Thompson
Journal:  Minerva Anestesiol       Date:  2012-11-22       Impact factor: 3.051
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.